Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0842-2021Class II

AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample...

Ansh Labs, LLC / initiated 2020-12-18 / Terminated / root cause: design

Ansh Labs, LLC began a recall of AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample DIL 1 x 100 mL, ENZ CONJ CONC 1 x 1.5 mL... on . FDA classified it as Class II and gives the reason as "Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0842-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Ansh Labs, LLC
Product
AnshLabs - SARS-CoV2 IgM ELISA (u-Capture), IVD, REF: AL-1002, kit contents, Ab PLATE 1 X ! Plate, IgM Sample DIL 1 x 100 mL, ENZ CONJ CONC 1 x 1.5 mL, Calibrators A-C 3 x 1.2 mL, CONJ DIL 1 X 12 mL, Stop SOLN 1 X 12 mL, TMB SOLN 1 X 12 mL, WASH CONC A 1 X 60 mL, (01)00853592008219 - Product Usage: intended for the qualitative detection of IgM antibodies in serum collected from the individuals suspected with signs and symptoms of COVID-19 infection by their healthcare provider.
Product code
QKO Reagent, Coronavirus Serological
Reason for recall
Labeling update; To reduce the risk of false positive/false negative results the IFU for the adaptive immune response to SRS-CoV-2 testing is being updated to remove Plasma as a "sample type" and to update the "limitation" section to include potential cross-reactivity with non-SARS-CoV2 strains.
Root cause tag
design
FDA root cause
Device Design
Action
On 12/18/2020 and on 12/30/2020, Ansh Labs, sent a "Urgent: Medical Device Voluntary Correction" notification to all affected consignees via E-Mail. In addition to informing consignees about the recall, the firm asked consignees to take the following actions: 1. Previous versions of SARS-CoV2 IgM ELISA IFU.AL.1002 (Revision No.: 01 - 04) should be removed and discarded. The attached updated revision, SARS-CoV2 IgM ELISA IFU.AL.1002 (Revision No.: 05) should be used. 2. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. 3. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. 4. Please complete and return the attached Acknowledgement and Receipt Form within 10 days so we are assured you have received this important communication. 5. If you have any questions, please contact Ansh Labs at 281-404-0260, Monday through Friday 8:30 AM to 5:30 PM, Central Standard Time or at [email protected]. www.anshlabs.com
Quantity in commerce
327 kits (93 test per kit)
Distribution
US Nationwide distribution including in the states of TX, MO, OK, MD, FL, NY, OR, GA, NC. OUS: None
Product codes and lots
Lot #/Expiration Date: 040720/2021-10-06, 041620/2021-10-15, 041720/2021-10-18, 042420/2021-10-15, 042720-A/2021-10-26

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0842-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0842-2021Class IITerminatedVoluntary: Firm initiated